Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Covid-19 Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05578391
What this trial is testing

Passive Immunotherapy In Patients With SARS CoV-2

Who this might be right for
COVID-19
Fundacin Biomedica Galicia Sur 61
Not applicableStudy completedNCT04542226
What this trial is testing

Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19

Who this might be right for
Infections, Coronavirus
NPO Petrovax 81
Post-approval studies (Phase 4)Study completedNCT06208540
What this trial is testing

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

Who this might be right for
Post-covid-19 Persistent Smell and Taste Disorders
Sherifa Ahmed Hamed 160
Early research (Phase 1)Active Not RecruitingNCT07095049
What this trial is testing

Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers

Who this might be right for
SARS-CoV-2 (COVID-19) Infection
Interna Therapeutics Ltd. 56
Testing effectiveness (Phase 2)Looking for participantsNCT06511050
What this trial is testing

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Who this might be right for
Long CovidPost-treatment Lyme Disease SyndromeChronic Fatigue Syndrome+1 more
Icahn School of Medicine at Mount Sinai 120
Not applicableWithdrawnNCT04468789
What this trial is testing

Evaluation of Six-month HIV Treatment Dispensing in South Africa

Who this might be right for
HIV
Boston University
Testing effectiveness (Phase 2)UnknownNCT04840459
What this trial is testing

Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Who this might be right for
Covid19
Sohail Rao 1,000
Very early researchUnknownNCT04371601
What this trial is testing

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

Who this might be right for
COVID-19 Pneumonia
Fuzhou General Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT05639192
What this trial is testing

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

Who this might be right for
COVID-19
Apogenix GmbH 34
Not applicableUnknownNCT05235386
What this trial is testing

Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.

Who this might be right for
COVID-19HypoxemiaHyperoxia+1 more
Laval University 60
Large-scale testing (Phase 3)Study completedNCT04492475
What this trial is testing

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 969
Large-scale testing (Phase 3)UnknownNCT04421534
What this trial is testing

Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19

Who this might be right for
COVID-19
Cairo University 150
Post-approval studies (Phase 4)Study completedNCT04792567
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

Who this might be right for
Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Ended earlyNCT04335071
What this trial is testing

Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Insel Gruppe AG, University Hospital Bern 5
Post-approval studies (Phase 4)Study completedNCT04710381
What this trial is testing

IMUNOR® Preparation in the Prevention of COVID-19

Who this might be right for
Covid19
University Hospital Ostrava 56
Not applicableStudy completedNCT04657471
What this trial is testing

Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study

Who this might be right for
Coronavirus Infection
University Hospital, Angers 1,300
Testing effectiveness (Phase 2)Ended earlyNCT04379518
What this trial is testing

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
Roswell Park Cancer Institute 4
Not applicableStudy completedNCT04724850
What this trial is testing

Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura

Who this might be right for
Coronavirus Disease 2019
Juan Fernando Masa Jiménez 440
Not applicableStudy completedNCT04380779
What this trial is testing

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

Who this might be right for
COVID-19
Manuel Monreal 2,430
Not applicableStudy completedNCT05910879
What this trial is testing

RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)

Who this might be right for
Health BehaviorHealth Care UtilizationVaccine Hesitancy
University of Oregon 625
Next Page